TY - JOUR
T1 - Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation
AU - Koehn, Brent H.
AU - Blazar, Bruce R.
N1 - Publisher Copyright:
© Society for Leukocyte Biology.
PY - 2017/8
Y1 - 2017/8
N2 - Graft-versus-host disease (GVHD) can be a devastating complication for as many as a third of patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT). A role for myeloid cells in the amplification of GVHD has been demonstrated; however, less is understood about a potential regulatory role that myeloid cells play or whether such cells may be manipulated and applied therapeutically. Myeloid-derived suppressor cells (MDSCs) are a naturally occurring immune regulatory population that are engaged and expand shortly after many forms of immune distress, including cancer, trauma, and infection. As MDSCs are often associated with chronic disease, inflammation, and even the promotion of tumor growth (regarding angiogenesis/metastasis), they can appear to be predictors of poor outcomes and therefore, vilified; yet, this association doesn’t match with their perceived function of suppressing inflammation. Here, we explore the role of MDSC in GVHD in an attempt to investigate potential synergies that may be promoted, leading to better patient outcomes after allo-HCT.
AB - Graft-versus-host disease (GVHD) can be a devastating complication for as many as a third of patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HCT). A role for myeloid cells in the amplification of GVHD has been demonstrated; however, less is understood about a potential regulatory role that myeloid cells play or whether such cells may be manipulated and applied therapeutically. Myeloid-derived suppressor cells (MDSCs) are a naturally occurring immune regulatory population that are engaged and expand shortly after many forms of immune distress, including cancer, trauma, and infection. As MDSCs are often associated with chronic disease, inflammation, and even the promotion of tumor growth (regarding angiogenesis/metastasis), they can appear to be predictors of poor outcomes and therefore, vilified; yet, this association doesn’t match with their perceived function of suppressing inflammation. Here, we explore the role of MDSC in GVHD in an attempt to investigate potential synergies that may be promoted, leading to better patient outcomes after allo-HCT.
KW - Cellular therapy
KW - GVHD
KW - Immune suppression
KW - Inflammation
KW - MDSC
UR - http://www.scopus.com/inward/record.url?scp=85026738613&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026738613&partnerID=8YFLogxK
U2 - 10.1189/jlb.5MR1116-464R
DO - 10.1189/jlb.5MR1116-464R
M3 - Review article
C2 - 28148718
AN - SCOPUS:85026738613
SN - 0741-5400
VL - 102
SP - 335
EP - 341
JO - Journal of Leukocyte Biology
JF - Journal of Leukocyte Biology
IS - 2
ER -